• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


mission

  1. When are they going to clean house with upper management?

    How can the family continue to let these incompetent unqualified people run their company into the ground?!? They already did one re-alignment and there is no way Mission can continue to keep the lights on without doing another in the near future. There is no communication, no products in the...